Research Implementation Partner for the Soar OVC Tender - 26608353
Tender notice from Tanzania, published on 12 Sep 2018.
Executive Summary
The ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION (EGPAF) has issued a Tender notice for the procurement of a Research Implementation Partner for the Soar OVC HIV Risk Screening Tool Validation Study in the Tanzania. This Tender notice was published on 12 Sep 2018 and is scheduled to close on 21 Sep 2018, with an estimated Tender value of Refer Document.
Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 26608353, while the tender notice number is and Register on the platform.
Key facts
Summary
Research Implementation Partner for the Soar OVC HIV Risk Screening Tool Validation Study
Request for proposals are invited for Research Implementation Partner for the Soar OVC HIV Risk Screening Tool Validation Study. The Elizabeth Glaser Pediatric AIDS Foundation, a non-profit organization, is the world leader in the fight to eliminate pediatric AIDS. Our mission is to prevent pediatric HIV infection and to eliminate pediatric AIDS through research, advocacy, and prevention and treatment programs. For more information, please visit http://www.pedaids.org. 1.1 BACKGROUND: The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is seeking a consultant/company to collect data related to a study entitled “Evaluating an HIV Risk Screening Tool in a Population of Orphans and Other Vulnerable Children Program Beneficiaries in Tanzania.” Efforts to identify children and adolescents for HIV testing have largely been conducted at the health facility level, where in-patient status or clinical symptom screening are often used as risk screening criteria to better target HIV testing services. This approach may miss many at risk children, such as orphans and other vulnerable children (OVC) served through community-based programs, if they do not regularly access facility services. Equipping community cadres with an appropriate tool to screen OVC for HIV risk at the community level could address this gap. Thus, integrating HIV risk screening into OVC programs can contribute to national and international “90-90-90” goals through improved identification of HIV-positive children/adolescents and linkage to treatment. A four-item HIV screening tool was developed and found to be effective in facility-based programs in Zimbabwe, but its effectiveness in an OVC population and as part of community-based screening is unknown. This study aims to determine the combination of items in the Kizazi Kipya (K2) risk screening tool that provides the best performance in the identification of true HIV-positive (sensitivity) and true HIV-negative OVC (specificity). 1.2 PURPOSE/SCOPE OF WORK: The goal of this proposed research is to evaluate the performance of items within the K2 OVC project HIV risk screening tool in identifying HIVpositive children and to optimize a community-based HIV screening tool for OVC. 1.2.1 Primary objectives: 1. To evaluate the performance of a four-item subset of the K2 HIV risk screening tool that matches the Zimbabwe evidence-based tool in predicting the HIV status of K2’s OVC beneficiaries who are screened by community case workers. 2. To identify additional items in the K2 risk screening tool that could be added to the fourquestion subset to improve the tool’s performance. 1.2.2 Secondary objectives: 1. To describe the HIV positivity rate among OVC in the K2 project who undergo HIV testing in the study. 2. To describe K2 OVC household HIV testing perceptions and HIV testing history of children and adolescents who undergo HIV testing in the study. 2.1 Study area: The study will take place in four regions of Tanzania, supported by the K2 program through the USAID-implementing partner, Pact. These regions are Dar es Salaam, Njombe, Shinyanga and Tabora. From these regions, a total of 7 councils; Temeke Municipal Council, Njombe Town Council, Njombe Districit Council, Kahama Town Council, Igunga District Council, Kaliua District Council and Nzega District Council, will be involved in the study. An estimated total of about 30 wards will be visited, but this may change if numbers of enrolled study participants, untested OVC or HIV positive yield are lower than anticipated. 2.2 Study design: This is a cross-sectional study of OVC K2 project beneficiaries. 2.3 Study Population: The study will involve OVC K2 project beneficiaries ages 2–19 years within selected geographic areas. The child/adolescent’s primary caregivers will also take part in the study as informants, representing the younger children/adolescents, and providing informed consent for study subjects under age 18. Children who are have documented HIV-positive status (HIV clinic enrollment evidence) will be excluded from the study. 2.4 Recruitment: Potential participants will be approached for this study in their homes as part of the HIV risk screening activity performed by K2-trained Community Case Workers (CCWs) in the civil society organizations (CSO) that partner with the K2 project to provide OVC supportive services. Trained research nurses (RNs) will be escorted by K2 project CCWs to K2-enrolled OVC households in the selected study wards during the study period. Only households enrolled in the K2 project will be visited. Per the K2 project, the CCW will administer the HIV risk screening tool to all of the OVC in the household. The CCW will introduce the study and the RN to the caregiver. All children in the household meeting the eligibility criteria will be recruited for the study. If no children are present at the OVC household when visited, at least one revisit to the household will be made if the children are expected to be there within a timeframe reasonable for the study. All attempted and completed household visits will be documented. The RN/CCW teams will plan to visit all OVC households and recruit all eligible OVC within each household in each study ward. Only consenting OVC/caregivers will be enrolled in the study. 2.5 Sample size: The study will recruit up to approximately 7, 000 children OVC aged 2-19 years in order to identify 81 HIV-positive OVC with complete data. 2.6 Data collection: There will be two main data sources:
i. Data provided by the K2 program, and
ii. Data collected by the study during household visits 2.6.1 Data from K2 program: The first type of K2 program data are the results of the CCW-administered HIV Risk Screening tool, which will be collected by the RN around the time of the household visit in the form of a carbon copy of the paper tool. The CCW will administer the 18-item HIV risk screening tool to all OVC in the household and will follow K2 programmatic standard operating procedures (SOPs) with regards to how they administer the tool. As screening is part of the K2 project, it will take place before study consent, the enrollment interview and HIV testing/counseling. The second type of K2 program data are the household level registration details which will be provided by K2 technical staff (based in Dar es Salaam). Nonidentifying data may be shared (e.g., location, household registration number) prior to field data collection for all K2-registered OVC households in study wards. 2.6.2 Data collected in the field: A short (4 page) structured interview will be conducted, and HIV counselling and testing. The RN will first administer a structured enrollment data collection form to capture relevant HIV testing information not already documented as part of the program, and reassess selected HIV risk screening items in order to describe agreement between CCWassessed and RN-assessed items. The form will be administered to caregivers, emancipated minors or adolescents 18–19 years of age, though non-emancipated younger children and adolescents may also participate in the interview. Pre/post-test counseling by RNs will be done according to study operating procedures which will be based upon national HIV testing guidelines (Tanzania Ministry of Health and Social Welfare 2013). RNs will also conduct HIV testing, using finger prick blood per national guidelines. Confidentiality, privacy and participant’s well-being will be safeguarded in this process. In case of HIV-positive results, the RN will follow national guidelines on referral to the HIV clinic for further counseling and support with respect to disclosure to the child (as applicable) and HIV treatment. Additionally, the RN will get permission from the caregiver (or child/adolescent as applicable) to share a copy of the completed referral form with the CCW so that ongoing K2 program support and follow-up is facilitated. Post-test HIV counseling for HIV-negative results will follow national guidelines and be tailored to individual situations.
The bid deadline for Research Implementation Partner for the Soar OVC HIV Risk Screening Tool Validation Study was 21 Sep 2018. Bidding is closed.
This tender has been issued by ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION (EGPAF) in Tanzania.
The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.
This tender is financed by United States Agency for International Development (USAID).
The tender is classified under the following CPV code(s): 73110000 - Research services.
The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.
The TendersOnTime reference is 26608353. The purchaser document reference is not provided in the notice.
Browse other tenders from Tanzania or search by relevant keywords and CPV classification.
This tender falls under Defence and Security in Tanzania. Suppliers in these sectors can track similar Tanzania tenders using CPV-based alerts.